• Fenipentol: Evidence, Identity, and Research Context

  2026-10-07

  Fenipentol, also called 1-Phenyl-1-pentanol, has been associated with historical hepatobiliary secretion research, but the supplied evidence contains important identity and provenance gaps. A 2024 antifibrotic study investigated the different positional isomer 1-phenyl-2-pentanol in hepatic stellate cells. This overview compares those evidence streams, explains what can and cannot be inferred, and outlines conceptual research questions without treating supplier claims as validated clinical or mechanistic conclusions.

• Amyloid β-Peptide (1-42): Evidence and Limits

  2026-10-07

  Amyloid β-Peptide (1-42), or Aβ42, is widely used to study amyloid aggregation, neuronal injury and Alzheimer’s disease mechanisms. This overview compares published evidence for ratiometric fibril imaging with supplier-reported assay claims, emphasizing what the data show, what remains uncertain and where in vitro findings should not be extrapolated.

• ABT-888 (Veliparib): A Biomarker-Aware View

  2026-10-06

  ABT-888 (Veliparib) is best understood not simply as a PARP inhibitor, but as a context-dependent probe of DNA repair and replication stress. This article connects its preclinical sensitization profile with recent evidence that PPP2R2A loss can redirect PARP-inhibitor-resistant ovarian cancer cells toward CHK1 dependence.

• Cefotaxime as a Lens on AMR Transmission

  2026-10-06

  Cefotaxime offers a useful mechanistic lens for connecting beta-lactam biology with antimicrobial resistance research. By placing the compound alongside recent evidence on carbapenemase-encoding genes in Enterobacter cloacae, this article distinguishes phenotypic activity from gene mobility, clonal spread, and clinical translation.

• Tigecycline Beyond the MIC: From Mechanism to Translation

  2026-10-05

  A translational perspective on Tigecycline that connects 30S ribosomal targeting, multidrug-resistant pathogen research, and the hospital-level resistance dynamics reported in carbapenem-resistant Enterobacter cloacae.

• Single-Cell ERK Dynamics in CRC Organoids

  2026-10-05

  Ponsioen and colleagues developed a live-cell, single-cell approach to quantify ERK signaling in patient-derived colorectal cancer organoids. Their findings show that EGFR amplifies, rather than merely initiates, oncogenic MAPK signaling in KRAS- and BRAF-mutant tumors, providing a mechanistic rationale for combining EGFR-directed treatment with downstream pathway strategies.

• Tigecycline: Evidence, Uses and Research Limits

  2026-10-04

  Tigecycline is a glycylcycline antibiotic with established clinical roles in selected complicated infections and continuing relevance to antimicrobial-resistance research. This overview compares pharmacologic rationale, clinical evidence and the 2025 Guangdong CREC study while emphasizing what the available data cannot establish about carbapenemase mobility or treatment outcomes.

• Arsenic Neurotoxicity, MMP-2/9, and BBB Injury

  2026-10-03

  A 2024 mouse study links sodium arsenite-associated learning and memory impairment with blood–brain barrier disruption, altered tight-junction proteins, MMP-2/MMP-9 elevation, and hippocampal neuronal apoptosis. Doxycycline hyclate intervention supported the proposed pathway by preserving barrier-associated findings and improving behavioral outcomes, while the pharmacological design does not establish exclusive or clinically transferable causality.

• 2'-O-Methyladenosine Assay Workflows

  2026-10-01

  Use 2'-O-Methyladenosine as a defined input for nucleoside transport, RNA modification, and purine metabolism experiments. A matrix-aware UHPLC–MS/MS workflow helps distinguish biological changes from ion suppression, isomer overlap, and sample-handling artifacts.

• AP1903: FKBP Dimerization for Cell Ablation

  2026-10-01

  AP1903 is an FKBP-binding ligand and chemical inducer of dimerization for controlled protein activation. Product data report nanomolar activity in F36V-FKBP assays, apoptosis induction in engineered HT1080 cells, and dose-dependent conditional cell ablation in mice.

• SM-164 and the Logic of Apoptotic Signal Testing

  2026-09-30

  SM-164 is a bivalent Smac mimetic that enables mechanistic analysis of IAP-dependent apoptosis. This article connects IAP antagonism with the newly defined Pol II degradation-dependent apoptotic response and shows how to separate target engagement, pathway signaling, and terminal cell-death readouts.

• Bestatin Reveals Jasmonate Signaling via Chemical Genetics

  2026-09-30

  The reference study establishes bestatin as a chemical probe that activates jasmonate-responsive processes in tomato and Arabidopsis while revealing that its activity depends on COI1 signaling but not strictly on jasmonate biosynthesis. By screening bestatin-resistant Arabidopsis mutants, the authors convert a small-molecule phenotype into a genetic strategy for identifying previously uncharacterized components of jasmonate signaling.

• 2',7'-Dichlorofluorescein Diacetate for ROS

  2026-09-29

  2',7'-Dichlorofluorescein diacetate is a cell-permeable fluorescent ROS probe for intracellular oxidative stress assay workflows. Its signal reports oxidation of intracellular dichlorofluorescein precursor pools, so it is useful for comparative measurements but is not a selective sensor for one reactive species.

• CpAdhE Inhibition by Antifungal Imidazoles

  2026-09-29

  The reference study identifies the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically vulnerable metabolic target in Cryptosporidium parvum. A tiered screen connected low-micromolar enzyme inhibition by several antifungal imidazoles with suppression of parasite growth in vitro, providing a useful framework for target-based anti-cryptosporidial discovery.

• Frizzled5 Couples Cholesterol to Wnt Signaling

  2026-09-28

  The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor that links lipid metabolism to receptor palmitoylation, plasma-membrane trafficking, and β-catenin signaling in pancreatic ductal adenocarcinoma. Its mechanistic framework clarifies why cholesterol supports selected Wnt-dependent tumors and provides a basis for testing receptor-directed metabolic interventions.

8488 records 1/566 page Next 12345 下5页 Last page